Versiti’s Banu Santebennur explains how clean data, semantic layers, and cautious tech adoption prepare clinical research for AI.
- Will AI And Agile Project Management Help Advance RBM?
- Building A Clinical Trial Tech Stack That Actually Works
- The Integration Dilemma: Who Decides Which Tech Stack Wins?
- Why Clinical Trial Sites Are Drowning In Tech Chaos
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Electronic Trial Master File: The Metrics
Here, the author defines several key ideas surrounding data, reports, and insights, honing in on one that is uniquely electronic and only possible because of the move to eTMF — Metrics!
-
Clinical Trials In The Age Of Cost Caps
On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.
-
On-Site ePRO In Action
Bridge the gap between clinic and home with flexible data capture. Use any device to ensure consistent, real-time data entry and improve compliance throughout the study lifecycle.
-
How Real-Time eTMFs Are Helping Keep Trials On Track
Learn how real-time dashboards assist with the sorting of information so clinical trial and medical affairs teams know what needs to be done, when, and by whom.
-
The Power Of Site Enablement Platforms As An Insurance Policy
Delve into the pivotal role played by this Site Enablement Platform in upholding business continuity for clinical trials.
-
Tech And Strategies For Reaching Underserved Patient Populations
By leveraging flexible solutions, learn how sponsors can proactively address regulatory mandates while advancing the development of safer and more effective therapies for a broader spectrum of patients.
-
5 Benefits Of Using A Study Management Tool
See how study management tools simplify clinical trial management by centralizing all study information, enhancing efficiency and precision, and more.
-
Vendor Selection Bias: Why Structured Decisions Often Fail
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
A Blueprint For Modern Obesity Research
The landscape of obesity and GLP-1 research has reached a saturation point. To successfully scale to the 5,000-patient registries now required for long-term evidence, a shift in operational architecture is essential.
-
Maximizing Clinical Data Insights With Advanced Analytics Platforms
To achieve drug approval, trials must collect, combine, and analyze diverse data sets that support operational, safety review, risk management, and other analyses crucial to development.
RECENT NEWSLETTERS
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch
- 07.03.26 -- Best Of June: AI, Data, And What's Fixing Trial Execution
- 07.02.26 -- How AI And Real-Time Tech Are Changing Trial Execution
- 06.25.26 -- How AI, Data, And Workflows Are Fixing Trial Execution
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials